118 related articles for article (PubMed ID: 12777880)
1. Administration of anti-interleukin-2Ralpha monoclonal antibody in bronchiolitis obliterans syndrome after lung transplantation.
Ding IB; Baumgartner RA; Schwaiblmair M; Behr J
Transplantation; 2003 May; 75(10):1767-9. PubMed ID: 12777880
[No Abstract] [Full Text] [Related]
2. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
Crowley S; Egan JJ
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
[TBL] [Abstract][Full Text] [Related]
3. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
4. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade.
Fullmer JJ; Fan LL; Dishop MK; Rodgers C; Krance R
Pediatrics; 2005 Sep; 116(3):767-70. PubMed ID: 16140721
[TBL] [Abstract][Full Text] [Related]
6. Bronchiolitis obliterans following lung transplantation.
Al-Githmi I; Batawil N; Shigemura N; Hsin M; Lee TW; He GW; Yim A
Eur J Cardiothorac Surg; 2006 Dec; 30(6):846-51. PubMed ID: 17055283
[TBL] [Abstract][Full Text] [Related]
7. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin and bronchiolitis obliterans.
Kanazawa S; Nomura S; Muramatsu M; Yamaguchi K; Fukuhara S
Am J Respir Crit Care Med; 2004 Mar; 169(5):654-5; author reply 655. PubMed ID: 14982826
[No Abstract] [Full Text] [Related]
9. Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems.
Akindipe O; Fernandez-Bussy S; Jantz M; Lu L; Deem A; Swafford W; Staples E; Baz M
Respirology; 2009 May; 14(4):601-5. PubMed ID: 19383111
[TBL] [Abstract][Full Text] [Related]
10. The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.
ter Meulen CG; Jacobs CW; Wetzels JF; Klasen IS; Hilbrands LB; Hoitsma AJ
Transplantation; 2004 Jan; 77(2):281-6. PubMed ID: 14742994
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure?
Fisher AJ
Eur Respir J; 2011 Jan; 37(1):10-2. PubMed ID: 21205711
[No Abstract] [Full Text] [Related]
12. [Bronchiolitis obliterans syndrome in lung transplant recipients].
Antus B; Fillinger J; Csiszér E; Czebe K; Horváth I
Orv Hetil; 2005 May; 146(19):953-8. PubMed ID: 15969307
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant bronchiolitis obliterans syndrome. Where have we been and where are we going?
Dauber JH
Chest; 1996 Apr; 109(4):857-9. PubMed ID: 8635356
[No Abstract] [Full Text] [Related]
15. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis.
Faro A; Shepherd R; Huddleston CB; Lowell J; Gandhi S; Nadler M; Sweet SC
Transplantation; 2007 Jun; 83(11):1435-9. PubMed ID: 17565316
[TBL] [Abstract][Full Text] [Related]
16. Obliterative bronchiolitis in the lung transplant recipient. A powerful foe.
Smith-Seiler DA; Iacono AT
Adv Nurse Pract; 2004 Apr; 12(4):69-74. PubMed ID: 15101139
[No Abstract] [Full Text] [Related]
17. Long-term outcome after pulmonary retransplantation.
Strueber M; Fischer S; Gottlieb J; Simon AR; Goerler H; Gohrbandt B; Welte T; Haverich A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):407-12. PubMed ID: 16872970
[TBL] [Abstract][Full Text] [Related]
18. What we expected all along: Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplantation!
Benden C
J Heart Lung Transplant; 2015 Apr; 34(4):501-2. PubMed ID: 25727772
[No Abstract] [Full Text] [Related]
19. Gastro-esophageal reflux as cause of obliterative bronchiolitis: a case report.
Rinaldi M; Martinelli L; Volpato G; Pederzolli C; Silvestri M; Pederzolli N; Arbustini E; Vigano M
Transplant Proc; 1995 Jun; 27(3):2006-7. PubMed ID: 7792868
[No Abstract] [Full Text] [Related]
20. Pirfenidone: anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients.
Dosanjh A
Eur J Pharmacol; 2006 May; 536(3):219-22. PubMed ID: 16581063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
